Research paperThe flanking peptides issue from the maturation of the human islet amyloid polypeptide (hIAPP) slightly modulate hIAPP-fibril formation but not hIAPP-induced cell death
Introduction
Protein misfolding and aggregation that lead to insoluble fibrils are the key factors for several human diseases, such as type 2 diabetes mellitus (T2DM), Alzheimer’s disease, Parkinson’s disease, Prion diseases as well as for many physiological processes [1,2]. In most of these misfolded protein diseases, the natively unfolded protein converts into insoluble ordered fibrillary aggregates, called as amyloid fibrils. The aggregation of amyloid proteins is a well-known process that leads to the formation of fibrils at the surface of cells, associated with cell toxicity [[2], [3], [4]]. In T2DM, the amyloid fibrils are found in the pancreatic islets of patients and are mainly composed of the human islet amyloid polypeptide (hIAPP), a 37 amino acid peptide (also known as amylin) [5,6].
hIAPP is coproduced and co-secreted along with insulin through the secretory pathway in a molar hIAPP:insulin ratio of 1:100 in healthy individuals, a ratio that can increase to 1:20 in T2DM [7,8]. During protein translation, hIAPP is processed and modified. Both hIAPP and insulin are secretory proteins initially synthesized as preprohormones that are released in response to stimuli [[9], [10], [11]]. Both hIAPP and insulin possess signal peptides that drive the targeting of nascent polypeptides from the cytosol to the endoplasmic reticulum (ER), the entry point into the secretory pathway [12,13]. The N-terminal signal peptides are removed by signal peptidase resulting in prohIAPP and proinsulin. In the oxidizing environment of the ER lumen, prohIAPP and proinsulin rapidly fold to form respectively one and three disulfide bonds, all evolutionary conserved. The resulting 67 amino acids prohIAPP and 86 amino acids proinsulin are cleaved in the trans-golgi network and then in the secretory granules by the prohormone convertases (PC1/3 and PC2) in concert with carboxypeptidase E (CPE) leading to the mature hIAPP and mature insulin. C-peptide resulting from proinsulin maturation as well as the two flanking peptides resulting from prohIAPP processing remain in the secretory granules.
The composition of the β-cell granule is extremely complex and contains many components that could influence hIAPP fibril formation and hIAPP toxicity. In fact, it is still not understood why and how hIAPP forms amyloid fibrils. However, several studies demonstrated that aggregation of amyloid proteins is easily influenced by both intrinsic features, such as mutations, expression levels, presence of peptides from the maturation, and by extrinsic factors, such as macromolecular crowding and interaction with metal ions, lipid membranes, or chaperones [[14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26]]. In the case of hIAPP, it was shown that divalent metal ion, Zn(II) and Cu(II) slowed down the kinetics of fibril formation, probably through the histidine residue at position 18 as a site of interaction and/or by forming a stable non fibrillar hIAPP-metal complex [17,[27], [28], [29]]. However, the role of Cu(II) in hIAPP-induced cell death has been controversial. A few studies demonstrated that hIAPP-induced INS-1 cells toxicity increased in the presence of Cu(II) [28,30,31] while another study on INS-1 cells and also on SHSY5Y cells, reported that copper ions do not affect hIAPP-induced cell death [29]. In addition to metal ions, granule peptides such as insulin and the C-peptide could also modify hIAPP fibril formation and hIAPP-induced cell death. Westermark et al. demonstrated first that insulin, even at a low concentration, significantly inhibited hIAPP fibril formation [32]. Later, several studies confirmed this statement and proposed different mechanism of an inhibition process [[33], [34], [35]]. Importantly, C-peptide, which do not form fibril itself, could reduce the amount of hIAPP fibrils [32]. It was shown that lowering pH to mimic the acid environment of the granules protects hIAPP from fibril formation in vitro [16] and that the histidine residue 18, the only residue that titrates over the pH range, plays an important role in hIAPP aggregation and misfolding [36]. Finally, a study revealed that the prohIAPP prevents aggregation and membrane damage of mature hIAPP [37]. However, no data are currently available on a putative function of both flanking peptides neither on their influence on hIAPP fibril formation and on hIAPP toxicity. Our goal was to determine if hIAPP flanking peptides could present some physiological properties and more specifically could form fibrils and/or affect hIAPP fibrillation and toxicity. This question about a functional role of hIAPP flanking peptide was asked, as the C-peptide, which comes from the insulin maturation process, has been described as an active molecule. Indeed, for a long time, it has been thought that the C-peptide has no physiological effect and it was used as a biomarker of pancreatic β-cell activity. Since the last 20 years, the interest upon a biological action of C-peptide has grown. So far, the physiological effect of C-peptide remains unknown. In contrast, in type 1 diabetic patients, a positive effect on microvascular complications of diabetes has been demonstrated. More specifically, the C-peptide plays a neuro- and a reno-protective effects, stimulates the pancreatic β-cell antioxidant capacity and could present an anti-inflammatory action [38]. It has also been proposed that the C-peptide could promote insulin release from it aggregated storage form, enhancing the insulin biological effect [39].
To shed light on hIAPP flanking peptides function, a comprehensive set of both biophysical experiments (fluorescence, circular dichroism, transmission electron microscopy) and biological studies were performed in solution, in the presence of membrane models, on culture cells and on human pancreatic islets. In particular, we investigated the ability of the flanking peptides to form fibrils, their secondary structures, their effect on mature hIAPP fibril formation and their influence on cell toxicity. We found in solution and in the presence of model membranes that the flanking peptides are not able to completely inhibit hIAPP fibril formation and hIAPP-induced membrane leakage. In the presence of INS-1 cells, the flanking peptides appear to have no effect on the hIAPP fibril formation neither on cell toxicity. However, in human pancreatic islets both flanking peptides slightly reduce hIAPP fibril formation but not hIAPP toxicity.
Section snippets
Materials
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-phospho-l-serine (DOPS) were obtained from Avanti Polar Lipids (Alabaster, USA). Thioflavin T (ThT) and calcein were obtained from Sigma-Aldrich (Saint Quentin Fallavier, France). Cell culture media were obtained from ThermoFisher scientific (France).
Peptide synthesis and preparation
Mature hIAPP and the two flanking peptides were synthesized with a CEM Liberty Blue (CEM corporation, Matthews, USA) automated microwave peptide synthesizer using
The flanking peptide are not amyloidogenic in solution
Fig. 1 shows steps of hIAPP maturation and peptides sequences. To predict the amyloidogenicity of the flanking peptides, we first analyzed their amino acids sequences in comparison with that of mature hIAPP using several standard amyloid prediction programs. The first method relies on individual amino acid aggregation propensities and on the composition of amyloidogenic regions. The two most popular programs, AGGRESCAN [42] and FoldAmyloid [43], demonstrate that the N-terminal flanking peptide
Discussions
Amyloid forming proteins are extremely sensitive to their environment therefore aggregation of amyloid proteins is easily influenced by both intrinsic and extrinsic factors. The relative importance of the flanking peptides and the possibility for interplay between mature hIAPP and the flanking peptides are the subject of the current investigation. In particular, we examine the potential alteration of mature hIAPP fibril formation, membrane damage and culture cells and human cells toxicity by
Conclusions
Our results suggest that the flanking peptides are not amyloidogenic in solution, neither in the presence of phospholipid membranes or cultured cells. In solution and in the presence of phospholipidic model membranes, the flanking peptides slightly reduced hIAPP fibril formation and hIAPP-membrane damage. In the presence of human islets, the flanking peptides have somewhat tendency to reduce hIAPP fibril formation, while the hIAPP-induced cell toxicity is not affected.
Based on the results
Author contributions
LK and GG designed the research; SSV, LK and GG performed experiments; PC and MA provided the human pancreatic islets; GG and LK interpreted data; GG and LK wrote the paper with input from BB. All the authors have approved the final article.
Funding
Sorbonne Université, CNRS, INSERM and the Saint-Antoine research center allowed this work to be performed.
Declaration of competing interest
No conflict of interest to declare.
Acknowledgements
Christophe Piesse (Institut de Biologie Paris Seine, Sorbonne Université, France) is acknowledged for the peptides synthesis. We thank Ghislaine Frebourg (Institut de Biologie Paris Seine, Sorbonne Université, France) for her help in the electron microscopy experiments.
References (62)
- et al.
Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats
Biochem. Biophys. Res. Commun.
(1991) - et al.
Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function
Regul. Pept.
(1993) - et al.
Structure and assembly mechanisms of toxic human islet amyloid polypeptide oligomers associated with copper
Chem. Sci.
(2016) - et al.
A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc
J. Mol. Biol.
(2011) - et al.
Phospholipid catalysis of diabetic amyloid assembly
J. Mol. Biol.
(2004) - et al.
Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers
FEBS (Fed. Eur. Biochem. Soc.) Lett.
(2004) - et al.
Pore formation by the cytotoxic islet amyloid peptide amylin
J. Biol. Chem.
(1996) - et al.
Copper(II) inhibits the formation of amylin amyloid in vitro
J. Inorg. Biochem.
(2008) - et al.
Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced beta cell apoptosis through induction of ROS-mediated mitochondrial dysfunction
J. Inorg. Biochem.
(2014) - et al.
Structure and assembly mechanisms of toxic human islet amyloid polypeptide oligomers associated with copper
Chem. Sci.
(2016)
Effects of beta cell granule components on human islet amyloid polypeptide fibril formation
FEBS Lett.
The mechanism of insulin action on islet amyloid polypeptide fiber formation
J. Mol. Biol.
Residue specific effects of human islet polypeptide amyloid on self-assembly and on cell toxicity
Biochimie
Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines
J. Immunol. Methods
Quantification of beta-sheet amyloid fibril structures with thioflavin T
Methods Enzymol.
Amyloid fibril formation from full-length and fragments of amylin
J. Struct. Biol.
Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation
Biochim. Biophys. Acta
Amyloid growth and membrane damage: current themes and emerging perspectives from theory and experiments on Aβ and hIAPP
Biochim. Biophys. Acta
A single mutation on the human amyloid polypeptide modulates fibril growth and affects the mechanism of amyloid-induced membrane damage
Biochim. Biophys. Acta
Human islet amyloid polypeptide (hIAPP) aggregation in type 2 diabetes: correlation between intrinsic physicochemical properties of hIAPP aggregates and their cytotoxicity
Int. J. Biol. Macromol.
IAPP in type II diabetes: basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies
Biochim. Biophys. Acta
Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide
Biochim. Biophys. Acta
Protein misfolding, functional amyloid, and human disease
Annu. Rev. Biochem.
Islet amyloid and type 2 diabetes mellitus
N. Engl. J. Med.
Islet amyloid polypeptide, islet amyloid, and diabetes mellitus
Physiol. Rev.
The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of langerhans
J. Exp. Med.
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
Proc. Natl. Acad. Sci. U.S.A.
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells
Proc. Natl. Acad. Sci. U.S.A.
Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes
J. Clin. Endocrinol. Metab.
Evidence of cosecretion of islet amyloid polypeptide and insulin by -cells
Diabetes
Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets
Diabetologia
Cited by (3)
Amyloid deposits in pancreatic islets, pathological functions and therapeutical targets
2024, Medecine des Maladies MetaboliquesInvestigation of the effects of two major secretory granules components, insulin and zinc, on human-IAPP amyloid aggregation and membrane damage
2021, Chemistry and Physics of LipidsCitation Excerpt :A previous study in the presence of membrane showed that i) the hIAPP precursors (ProhIAPP and ProhIAPP1−48) do not form fibrils and ii) both precursors reduced the level of hIAPP fibril formation from 100 % to around 60 % (Khemtémourian et al., 2009). In another study, it was observed that the flanking peptides issue from the maturation of ProhIAPP to hIAPP do not form fibrils but only slightly reduce hIAPP fibril formation (Salazar Vazquez et al., 2020). Another potential inhibitor present in a high concentration in the granules is insulin.
Introduction and Fundamentals of Human Islet Amyloid Polypeptide Inhibitors
2020, ACS Applied Bio Materials
- 1
GG and LK contributed equally to the publication.